Latest UpdateJune 27, 2025 - New variant information availableLearn More →

BA.2.86

SARS-CoV-2 Omicron BA.2.86

Severity: MediumVariant Under MonitoringStable

BA.2.86 represents a highly divergent Omicron subvariant with numerous spike protein mutations.

Quick Facts

First Detected:July 2023
Countries:45+
Last Updated:2025-06-20

Transmissibility

Moderate transmissibility

Vaccine Evasion

Significant antigenic change from XBB variants

Global Prevalence

Low but persistent circulation

Symptoms & Signs

Common Symptoms

Respiratory symptoms
Fatigue
Headache
Sore throat

Distinctive Features

Similar to other Omicron variants

Prevention & Treatment

Prevention Strategies

Updated 2023-2024 vaccines
Targeted masking
Ventilation improvements
Regular health monitoring

Treatment Options

Standard COVID-19 treatments remain effective

Key Mutations

30+ mutations in spike protein

Global Surveillance

Countries Reporting45+
Global CasesLimited global circulation
Current TrendStable

Key Research Findings

Extensive mutations raised initial concern

Lower transmissibility than initially feared

Parent lineage to more successful JN.1

Important for vaccine strain selection

High-Risk Groups

Immunocompromised patients
Older adults
Chronic disease patients
Healthcare workers

Medical Disclaimer

This information is for educational purposes only and should not replace professional medical advice. Always consult with qualified healthcare providers for diagnosis, treatment, and medical guidance. Information last updated: 2025-06-20.